RARRES2 and rheumatoid arthritis: Evidences showed that circulating levels of chemerin significantly increased in rheumatoid arthritis patients accompanied with cardiovascular disease, gestational hypertension, metabolic syndrome, dilated cardiomyopathy, and advanced carotid stenosis [9–13].